39061-97-7
39061-97-7 structure
- Name: 4-Chloro-3-nitroquinoline
- Chemical Name: 4-Chloro-3-nitroquinoline
- CAS Number: 39061-97-7
- Molecular Formula: C9H5ClN2O2
- Molecular Weight: 208.601
- Catalog: Pharmaceutical intermediate Heterocyclic compound Quinoline compound
- Create Date: 2018-06-15 19:50:55
- Modify Date: 2025-08-25 14:42:30
| Name | 4-Chloro-3-nitroquinoline |
|---|---|
| Synonyms |
4-Chloro-3-nitroquinoline
3-Nitro-4-chloroquinoline 4-Chloro-3-nitroqulinoline Quinoline, 4-chloro-3-nitro- 4-Chloro-3-nitro-quinoline MFCD07369246 4-Chlor-3-nitro-chinolin QUINOLINE,4-CHLORO-3-NITRO |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 333.8±22.0 °C at 760 mmHg |
| Melting Point | 121-122°C |
| Molecular Formula | C9H5ClN2O2 |
| Molecular Weight | 208.601 |
| Flash Point | 155.7±22.3 °C |
| Exact Mass | 208.003952 |
| PSA | 58.71000 |
| LogP | 2.46 |
| Vapour Pressure | 0.0±0.7 mmHg at 25°C |
| Index of Refraction | 1.688 |
| Storage condition | -20?C Freezer, Under Inert Atmosphere |
| Hazard Codes | T |
|---|---|
| Risk Phrases | R23/24/25:Toxic by inhalation, in contact with skin and if swallowed . R34:Causes burns. |
| Safety Phrases | S26-S36/37/39-S45 |
| RIDADR | UN 3288 6.1/PG 2 |
| WGK Germany | 3 |
| Packaging Group | III |
| Hazard Class | 6.1(b) |
| HS Code | 2933499090 |
|
~94%
39061-97-7 |
| Literature: CAYLA; VERNEJOUL, Fabienne; DEBIN, Arnaud; DROCOURT, Daniel; PEROUZEL, Eric; TIRABY, Gerard; LIOUX, Thierry Patent: US2014/141033 A1, 2014 ; Location in patent: Page/Page column ; |
|
~%
39061-97-7 |
| Literature: Dainippon Sumitomo Pharma Co. Ltd.; AstraZeneca AB Patent: US2011/136801 A1, 2011 ; |
|
~%
39061-97-7 |
| Literature: Bachman et al. Journal of the American Chemical Society, 1947 , vol. 69, p. 365,370 |
|
~%
39061-97-7 |
| Literature: Bachman et al. Journal of the American Chemical Society, 1947 , vol. 69, p. 365,370 |
|
~%
39061-97-7 |
| Literature: Takada, Susumu; Sasatani, Takashi; Chomei, Nobuo; Adachi, Makoto; Fujishita, Toshio; Eigyo, Masami; Murata, Shunji; Kawasaki, Kazuo; Matsushita, Akira Journal of Medicinal Chemistry, 1996 , vol. 39, # 14 p. 2844 - 2851 |
|
~%
39061-97-7 |
| Literature: Goeblyoes, Aniko; Gao, Zhan-Guo; Brussee, Johannes; Connestari, Roberto; Santiago, Sabrina Neves; Ye, Kai; Ijzerman, Adriaan P.; Jacobson, Kenneth A. Journal of Medicinal Chemistry, 2006 , vol. 49, # 11 p. 3354 - 3361 |
|
~%
39061-97-7 |
| Literature: Ochiai; Kaneko Pharmaceutical Bulletin, 1957 , vol. 5, p. 56,60 |
| Precursor 7 | |
|---|---|
| DownStream 10 | |
![2-ethyl-1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine structure](https://image.chemsrc.com/caspic/245/149876-20-0.png)
![N-[1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-yl]benzamide structure](https://image.chemsrc.com/caspic/101/144660-62-8.png)
![4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline structure](https://image.chemsrc.com/caspic/214/99010-64-7.png)
| HS Code | 2933499090 |
|---|---|
| Summary | 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |